INTELICARE HOLDINGS LIMITED — Capital/Financing Update 2021

Nov 14, 2021

15[th] November 2021

==> picture [150 x 65] intentionally omitted <==

InteliCare Holdings Ltd

ASX Code

Entitlement Offer to raise up to $2.99 million.

The Board of InteliCare Holding Limited ( Company ) (ASX: ICR) is pleased to announce an offer to raise up to $2.99 million.

Eligible shareholders of the Company will be invited to participate in a nonrenounceable, pro rata offer on the basis of 1 fully paid ordinary share ( New Share ) for every 2.25 Shares held as at 5.00pm (Perth time) on Friday, 19 November 2021 ( Record Date ) at an issue price of $0.08 per new share ( Entitlement Offer ).

Use of funds

Managing Director

Non-Exec Chairman

Subject to the satisfactory completion of the Entitlement Offer, funds raised pursuant to the Entitlement Offer are intended to be used towards sales and marketing, research and development, and to cover the costs of the Entitlement Offer.

Key dates

The indicative timetable for the Entitlement Offer is as follows:

Issued Shares

Unlisted Options

Website

Office

Event	Date
Announcement of Entitlement Offer, Appendix 3B, and Offer Booklet	Monday, 15 November 2021
Ex date	Thursday, 18 November 2021
Record Date	Friday, 19 November 2021
Opening Date Dispatch of Offer Booklet and Entitlement and Acceptance Forms	Wednesday, 24 November 2021
Last day to extend the Closing Date	Friday, 3 December 2021 (before noon)
Closing Date (5pm)	Wednesday, 8 December 2021
New Shares quoted on a deferred settlement basis	Thursday, 9 December 2021
Announcement of results of Entitlement Offer	Friday, 10 December 2021
Issue of New Shares under Entitlement Offer Lodgement of Appendix 2A applying for quotation of the new shares	Wednesday, 15 December 2021
Quotation of New Shares under Entitlement Offer	Thursday, 16 December 2021

==> picture [61 x 29] intentionally omitted <==

Eligible Shareholders that wish to participate in the Entitlement Offer are encouraged to subscribe for New Shares as soon as possible after the Entitlement Offer opens. The Company reserves the right, subject to the Corporations Act, the ASX Listing Rules and other applicable laws, to vary the dates of the Entitlement Offer (including extending the Entitlement Offer or accepting late applications) without notice.

Entitlement Offer details

Shareholders will be eligible to participate in the Entitlement Offer if they are on the share register of the Company as at the Record Date with a registered address in Australia or New Zealand ( Eligible Shareholders ).

All Shares issued under the Entitlement Offer will rank equally with existing Shares of the Company as of the date of this announcement.

In addition, Eligible Shareholders who take up their full entitlement under the Entitlement Offer will have the opportunity to apply for additional Shares ( Additional New Shares ) in excess of their entitlement through a shortfall facility ( Shortfall Facility ). Any Additional New Shares will be limited to the extent there are sufficient New Shares from Eligible Shareholders who do not take up their full Entitlements or from New Shares that would have been offered to ineligible Shareholders if they had been entitled to participate in the Entitlement Offer.

There is no guarantee that Eligible Shareholders who apply for Additional New Shares under the Shortfall Facility will receive all or any Additional New Shares applied for under the Shortfall Facility. Refer to the Offer Booklet for further details regarding the Company's allocation policy for the Shortfall Facility.

If any shortfall remains after the issue of Additional New Shares to Eligible Shareholders as contemplated by the Shortfall Facility described above, the shortfall will be allocated in accordance with the terms of the underwriting agreement.

The Entitlement Offer is non-renounceable, and the rights will not be able to be traded on the ASX and will not be transferable.

Eligible Shareholders wishing to participate in the Entitlement Offer should carefully read the Offer Booklet and accompanying personalised Entitlement and Acceptance Form which are expected to be dispatched to Eligible Shareholders on or around Wednesday, 24 November 2021.

A copy of the Offer Booklet will be announced on the ASX and available on the Company’s website.

The Entitlement Offer is made pursuant to section 708AA of the Corporations Act 2001 (Cth) ( Corporations Act ) (as modified by ASIC Corporations (Non-Traditional Rights Issues) Instrument 2016/84).

Westar Capital Ltd has been appointed as lead manager of and underwriter to the Entitlement Offer and Shortfall Facility. Westar will receive 6% of the gross amount raised by the Entitlement Offer, including Shares issued under the Shortfall Facility and underwriting. Westar will also

==> picture [198 x 19] intentionally omitted <==

==> picture [61 x 29] intentionally omitted <==

Intelicare Holdings Ltd ABN: 84 622 484 397 T: 1300 001 145 A: 299 Vincent St, Leederville, WA 6007

receive 12,500,000 unquoted options with an exercise price of $0.16 and exercisable within 3 years from the date of issue.

This announcement is approved for release by the Board of InteliCare Holdings Limited.

For more information regarding InteliCare, visit www.intelicare.com.au.

Contact and Authorised for Release to the ASX

Jason Waller, Chief Executive Officer and Managing Director, InteliCare Holdings Ltd, +61 1300 001 145 , investors@intelicare.com.au

About Intelicare Holdings Limited

InteliCare is an Australian technology company that has commercialised a predictive analytics hardware and software system for use in the aged care and health industries. InteliCare believes Australians deserve to age with dignity and through its business-to-business (B2B) and business-to-consumer (B2C) solutions built on its proprietary internet of things (IOT) platform utilising smart sensors and artificial intelligence (AI), InteliCare aims to enable people to stay in their own homes for longer while empowering healthcare providers to deliver higher quality, more efficient services.

==> picture [198 x 19] intentionally omitted <==

==> picture [61 x 29] intentionally omitted <==

Intelicare Holdings Ltd ABN: 84 622 484 397 T: 1300 001 145 A: 299 Vincent St, Leederville, WA 6007